查詢結果分析
來源資料
相關文獻
- 精泰來治療男性免疫性不育的療效和安全性
- Anticoagulation in Acute Ischemic Stroke
- Comparing the Efficacy and Safety of Atorvastatin and Simvastatin in Asians with Elevated Low-Density Lipoprotein-Cholesterol--A Multinational, Multicenter, Double-Blind Study
- Comparative Study of Compliance, Antitussive Efficacy and Tolerability between Detusiv[feb9] Sustained Release Tablet and Medicon-A[feb9] Capsule in the Treatment of Acute Cough
- 從統計角度來判斷藥物臨床試驗所具有之臨床價值
- The Efficacy and Safety of Recombinant Tissue Plasminogen Activator Infusion in Acute Myocardial Infarction
- 臺灣地區異位性皮膚炎患者使用tacrolimus油膏之療效與安全性評估
- CETP Inhibitor的療效與安全性
- 不同定義日劑量的Statins類降血脂藥品於高血壓患者之臨床療效與安全性評估
- A Randomized, Open-Labeled and Controlled Study of the Efficacy and Safety of Kludone Modified Release in the Treatment of Chinese Type 2 Diabetic Patients
頁籤選單縮合
| 題 名 | 精泰來治療男性免疫性不育的療效和安全性=Efficacy and Safety of JingTaiLai in the Treatment of Male Immune Infertility |
|---|---|
| 作 者 | 徐福松; 時永華; 劉承勇; 何映; 寧克勤; 王慶; 黃健; 孫志興; 池雷; | 書刊名 | 中醫婦科醫學雜誌 |
| 卷 期 | 18 2014.06[民103.06] |
| 頁 次 | 頁28-33 |
| 分類號 | 413.34 |
| 關鍵詞 | 精泰來; 男性免疫性不育; 療效; 安全性; JingTaiLai; Male immune infertility; Efficacy; Safely; |
| 語 文 | 中文(Chinese) |
| 中文摘要 | 目的:評估精泰來治療男性免疫性不育的存效件和安全性。方法:198例病人隨機進入精泰來組和強的松組。進行6個月治療和6個月隨訪共12個月的隨機平行對照試驗。結果:抗精子抗體轉陰率精泰來組為83.2%,強的松組64.8%;懷孕率分別為48.7%和18.0%兩組比較有明顯差異(P < 0.05),不良反應的發生率精泰來與強的松分別為15.1%和20.4%,結論:精泰來可存效治療男性免疫性不育,並有較好的耐受性。 |
| 英文摘要 | To evaluate the efficacy and safety of Jing-tai-lai (JFL) on male immune infertility. Methods: This study Was a randomized parallel control trial over 12 months. A total number of 198 men were randomly divided into JFL and prednisone treatment gurups. Resists: The pregnancy rate of the JTL group and the prednisone group were 48.7% and 18.0% respectively. The rates of antisperm antibody turned negative were 83.2% and 64.8%. The fonner was significantly lugher as compared with the latter (P < 0.05). The adverse reactions were lover for JFL (15.1%) than for prednisone (20.4%). Conclusions: JTL is an effective. Well-tolerated Chinese medicine. |
本系統中英文摘要資訊取自各篇刊載內容。